PR Newswire | Oct 19, 2020 08:15AM EDT

Annual Meeting Highlighting Advancements in Intelligent Cancer Care(tm)

10/19 07:15 CDT

Varian Announces Presence at American Society for Radiation Oncology (ASTRO) Annual Meeting Highlighting Advancements in Intelligent Cancer Care(tm)- Five Oral Presentations, Ten Digital Posters Highlight Varian Products and Innovation- Ethos(r) Data Presented in Five Types of Cancer, Demonstrating Benefits of Adaptive Therapy- First Data from Newly-Formed AI-Driven Adaptive Intelligence Consortium Presented PALO ALTO, Calif., Oct. 19, 2020

PALO ALTO, Calif., Oct. 19, 2020 /PRNewswire/ -- Varian (NYSE: VAR), a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intelligent Cancer Care(tm) during the 2020 American Society for Radiation Oncology (ASTRO) taking place virtually from October 24-31. At this year's show, the company will showcase its progress in helping more people access advanced cancer care, making cancer care more personalized, and delivering more data-driven insights to improve efficiencies and outcomes. In addition to a "best in class" virtual experience, Varian's contributions to Intelligent Cancer Care will be highlighted in eleven presentations including data from the use of Varian's adaptive radiotherapy system, Ethos(r), for lung, prostate, bladder, upper abdomen, head & neck cancers, and the first-look data presented by the recently-formed AI-driven Adaptive Intelligence Consortium.

"Despite the transition to a virtual platform, our entire global Varian team is looking forward to connecting with ASTRO 2020 attendees and showcasing our innovations that help providers deliver the best cancer care to patients throughout their entire journey," said Dow Wilson, Chief Executive Officer of Varian. "Since its launch at last year's ASTRO, our Ethos(r) Therapy has demonstrated significant impact toward personalizing treatment for patients resulting in 10 featured presentations during this year's meeting."

At this year's virtual event, Varian will participate with a dynamic booth presence and provide one-on-one product demonstrations, as well as highlight how it pioneers for the future with sessions during the ASTRO Innovation Hub. The company will also have a presence at the American Society of Radiologic Technologists (ASRT) and Society of Radiation Oncology Administrators (SROA) concurrent meetings. Attendees can register for all Varian educational and demo sessions at https://www.varian.com/resources-support/events/virtual-events

ASTRO attendees will be able to view the following data presentations featuring Varian products and innovation. Registration links are available here: https://www.astro.org/Meetings-and-Education/Micro-Sites/2020/Annual-Meeting/Register

Topic Session/Time and Day

Brain - Semi-Automated Hippocampal Sparing Avoidance Digital Poster Q&ACancer Whole-Brain Radiotherapy Using a Commercially Available Artificial Intelligence Toolkit Oct 25, 2:00 p.m. ET

Upper - Feasibility of AI-assisted CBCT-guided Oral PresentationsAbdomen Stereotactic Online Adaptive RadiotherapyCancer (CT-STAR) for Upper Abdominal SBRT: Results of Oct 25, 9:10 a.m. ET a Prospective in Silico Clinical Trial

- Evaluation and validation of artificial intelligence (AI) delineation models for Oct 25, 12:20 a.m. ET CBCT-guided stereotactic online adaptive radiotherapy (STAR) targeting upper abdominal malignancies

Prostate - Adaptive radiotherapy can be applied Digital Poster Q&ACancer routinely, using an artificial intelligence solution, to treat prostate cancer patients Oct 25, 2:15 p.m. ET

Head & - Evaluation of dosimetric quality of Digital Posters Q&ANeck auto-generated plans by a novel online adaptiveCancer system for head and neck radiotherapy Oct 25, 2:15 p.m. ET

- Evaluation of the Auto-Segmentation Performance of a Novel Online Adaptive Oct 25, 2:15 p.m. ET Radiotherapy System for Head and Neck Cancer Treatment

- Head and neck quad shot using CT based Oct 26, 4:30 p.m. ET adaptive treatment on a ring gantry LINAC

AI and - First AI-driven Adaptive System-International Oral PresentationCancer Consortium lead Failure Mode and EffectTreatment Analysis (FMEA) Oct 26, 12:50 a.m. ET

- Results of a pilot study on online adaptive Oral PresentationBladder radiotherapy of bladder cancer with artificialCancer intelligence-driven full re-optimization on the Oct 27, 1:00 a.m. ET anatomy of the day

Lung - Improved treatment quality in stage III lung Digital Poster Q&ACancer cancer patients using online adaptive radiotherapy in a simulation setting Oct 27, 2:00 p.m. ET

- Accuracy of the Treatment Plan Dose Preview Digital Posters Q&ATreatment Functionality of a Newly Commercially-Planning Available, CBCT-Based, Online Adaptive Oct 25, 2:15 p.m. ET Radiotherapy Treatment System

- Data-Driven Margin Determination for Online Adaptive Radiotherapy Using Batch Automated Oct 25, 2:15 p.m. ET Planning

- Plan quality and fidelity evaluation of CBCT-Guided stereotactic online adaptive Oct 28, 2:00 p.m. ET radiotherapy (CT-STAR) with an artificial intelligence (AI) aided plan re-optimization

- Dosimetric Impact and Required Clinician Time Digital Poster Q&AClinical of Online Adaptive Radiotherapy using a NewlyWorkflow Commercially-Available, CBCT-Based Adaptive Oct 25, 2:15 p.m. ET Treatment System

- Feasibility of Expediting Radiotherapy Oral Presentation Clinical Workflow by Planning on Diagnostic Images and Adapting on a Commercial Adaptive Oct 28, 3:15 p.m. ET Radiotherapy System

About VarianAt Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press ContactsAimee CorsoHealth+Commerce+1 (310) 780-2661aimee@healthandcommerce.com

Investor Relations ContactAnshul MaheshwariVice President, Investor Relations+1 (650) 424-5631investors@varian.com

View original content: http://www.prnewswire.com/news-releases/varian-announces-presence-at-american-society-for-radiation-oncology-astro-annual-meeting-highlighting-advancements-in-intelligent-cancer-care-301154021.html

SOURCE Varian